AD involves a combination of processes, including decreased acetylcholinesterase levels, reduced insulin sensitivity, the accumulation of advanced glycation end-products (AGEs), the dysfunction of APOE, etc. Hence, it is of utmost importance to develop an animal model of Late-Onset Alzheimer’s Disease (LOAD) that accurately replicates the pathology observed in humans. Here, APOE is linked to Alzheimer disease.